Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 14 of about 14 for Merck & Co., Inc.�
Company Exchange Symbol Last price Quote change Market cap
Ligand Pharmaceuticals Inc. NASDAQ LGND 56.92 -0.11 (-0.19%) 1.13B
Ligand Pharmaceuticals Incorporated (Ligand) is a biotechnology company that operates with a business model focused on developing or acquiring assets.
Merck & Co., Inc. NYSE MRK 60.28 -1.81 (-2.92%) 175.38B
Merck & Co., Inc. is a health care company that offers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, ...
Enzon Pharmaceuticals Inc NASDAQ ENZN 0.963 -0.037 (-3.69%) 44.50M
Enzon Pharmaceuticals, Inc. (Enzon) is a biotechnology company. The Company's drug development programs utilize two platforms: Customized PEGylation Linker ...
Xenon Pharmaceuticals Inc NASDAQ XENE 17.79 +0.55 (3.19%) 250.40M
(Teva) (through its subsidiary, Ivax International GmbH), Genentech, Inc. ( Genentech), and Merck & Co., Inc. (Merck) (through its affiliate, Essex Chemie ...
Alkermes Plc NASDAQ ALKS 72.25 +0.06 (0.08%) 10.54B
Alkermes Public Limited Company is an integrated, global biopharmaceutical company. The Company has a portfolio of more than 20 commercial drug products and ...
Par Pharmaceutical Companies, Inc. NYSE PRX 0.0000
Par Pharmaceutical Companies, Inc. is a holding company that, principally through its wholly owned operating subsidiary, Par Pharmaceutical, Inc., ...
Nektar Therapeutics NASDAQ NKTR 14.64 -0.42 (-2.79%) 1.94B
Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms.
MERCK AND CO INC EPA MRK 54.00 +0.10 (0.19%)
XENON PHARMACEUTICALS FRA XP0 15.01 +0.07 (0.44%)
ENZON PHARMACEUT. DL-,01 FRA EZ1 0.850 -0.016 (-1.85%)
PAR PHARMACEUT. DL-,01 FRA PZJ 37.93
ALKERMES PLC DL-,01 FRA 8AK 64.19 +0.68 (1.08%)
NEKTAR THERAPEUTICS FRA ITH 13.10 +0.35 (2.79%)
MERCK & CO INC CEDEAR (10 REP 1 USD0.50) BCBA MRK 0.0000